Literature DB >> 19945701

The metabolic syndrome predicts incident congestive heart failure: a 20-year follow-up study of elderly Finns.

Jianjun Wang1, Katriina Sarnola, Sanna Ruotsalainen, Leena Moilanen, Päivi Lepistö, Markku Laakso, Johanna Kuusisto.   

Abstract

OBJECTIVE: We investigated whether the metabolic syndrome (MetS) and its components defined by four different criteria including subjects with prevalent diabetes in their definitions were associated with congestive heart failure (CHF) independent of interim myocardial infarction (MI) and prevalent diabetes during a 20-year follow-up in an elderly population-based study. METHODS AND
RESULTS: The MetS was defined according to the World Health Organization (WHO), the National Cholesterol Education Program (NCEP), the International Diabetes Federation (IDF), and the American Heart Association and the National Heart, Lung, and Blood Institute (AHA) criteria. The association of the MetS with incident CHF (303 cases) was investigated with Cox regression analyses in a 20-year follow-up study of 1032 Finns, aged 65-74 years at baseline. Among all subjects the MetS by all four criteria was significantly associated with a 1.45-1.74-fold risk for incident CHF after the adjustment for confounding factors. When subjects with interim MI during the follow-up and with prevalent diabetes were excluded, the MetS was significantly associated with a 1.37-1.87-fold risk for incident CHF after the adjustment for confounding factors. Of the single components of the MetS, the following were associated with incident CHF: impaired fasting glucose (IFG) [fasting plasma glucose (FPG)> or = 6.1 mmol/l, Hazards ratio (HR) 1.46 or FPG > or = 5.6 mmol/l, HR 1.62)]; raised blood pressure (BP) [(BP > or = 140/90 mmHg or antihypertensive medications, HR 1.89); central obesity (waist circumference > or = 94 cm in men or > or = 80 cm in women, HR 1.49); (waist circumference > or = 102 cm in men or > or = 88 cm in women, HR 1.48); obesity (body mass index > or = 30 kg/m(2), HR 1.79); and low high-density lipoprotein cholesterol (<1.03 mmol/l in men or <1.29 mmol/l in women, HR 1.55).
CONCLUSIONS: The MetS defined by four different criteria predicted CHF independent of interim MI and prevalent diabetes in elderly Finns, but not above and beyond the risk associated with one component of the MetS, hypertension. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19945701     DOI: 10.1016/j.atherosclerosis.2009.10.042

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  25 in total

Review 1.  Mineralocorticoid receptor antagonists and the metabolic syndrome.

Authors:  Amir Tirosh; Rajesh Garg; Gail K Adler
Journal:  Curr Hypertens Rep       Date:  2010-08       Impact factor: 5.369

2.  Should we target obesity in advanced heart failure?

Authors:  Amanda R Vest; James B Young
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-02

3.  [Diabetes and heart failure].

Authors:  Christian A Schneider; Roman Pfister; Erland Erdmann
Journal:  Herz       Date:  2010-05       Impact factor: 1.443

4.  Recovery of Serum Cholesterol Predicts Survival After Left Ventricular Assist Device Implantation.

Authors:  Amanda R Vest; Peter J Kennel; Dawn Maldonado; James B Young; Maria M Mountis; Yoshifumi Naka; Paolo C Colombo; Donna M Mancini; Randall C Starling; P Christian Schulze
Journal:  Circ Heart Fail       Date:  2016-09       Impact factor: 8.790

5.  Association of lipids with incident heart failure among adults with and without diabetes mellitus: Multiethnic Study of Atherosclerosis.

Authors:  Imo A Ebong; David C Goff; Carlos J Rodriguez; Haiying Chen; Christopher T Sibley; Alain G Bertoni
Journal:  Circ Heart Fail       Date:  2013-03-25       Impact factor: 8.790

6.  The Ets-1 transcription factor is involved in the development and invasion of malignant melanoma.

Authors:  T Rothhammer; J C Hahne; A Florin; I Poser; F Soncin; N Wernert; A-K Bosserhoff
Journal:  Cell Mol Life Sci       Date:  2004-01       Impact factor: 9.261

7.  The association of non-alcoholic fatty liver disease and cardiac structure and function-Framingham Heart Study.

Authors:  Laura S Chiu; Alison Pedley; Joseph M Massaro; Emelia J Benjamin; Gary F Mitchell; David D McManus; Jayashri Aragam; Ramachandran S Vasan; Susan Cheng; Michelle T Long
Journal:  Liver Int       Date:  2020-07-25       Impact factor: 5.828

8.  Plasma phospholipid fatty acid composition and estimated desaturase activity in heart failure patients with metabolic syndrome.

Authors:  Seungmin Lee; Hyun Ju Do; Seok-Min Kang; Ji Hyung Chung; Eunju Park; Min-Jeong Shin
Journal:  J Clin Biochem Nutr       Date:  2012-07-06       Impact factor: 3.114

9.  Inverse association of long-acting natriuretic peptide with metabolic syndrome in congestive heart failure patients.

Authors:  Ji-Hung Wang; Chung-Jen Lee; Jen-Che Hsieh; Yu-Chih Chen; Bang-Gee Hsu
Journal:  Diabetol Metab Syndr       Date:  2013-04-08       Impact factor: 3.320

10.  The prognostic implication of metabolic syndrome in patients with heart failure.

Authors:  Hyun Ju Yoon; Youngkeun Ahn; Kye Hun Kim; Jong Chun Park; Dong-Ju Choi; Seongwoo Han; Eun-Seok Jeon; Myung-Chan Cho; Jae-Joong Kim; Byung-Su Yoo; Mi-Seung Shin; In-Whan Seong; Seok-Min Kang; Yung-Jo Kim; Hyung Seop Kim; Shung Chull Chae; Byung-Hee Oh; Myung-Mook Lee; Kyu-Hyung Ryu
Journal:  Korean Circ J       Date:  2013-02-28       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.